Cargando…
[Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603549/ https://www.ncbi.nlm.nih.gov/pubmed/37830166 http://dx.doi.org/10.3892/or.2023.8646 |
_version_ | 1785126628638064640 |
---|---|
author | Račkauskas, Rokas Zhou, Dachen Ūselis, Simonas Strupas, Kęstutis Herr, Ingrid Schemmer, Peter |
author_facet | Račkauskas, Rokas Zhou, Dachen Ūselis, Simonas Strupas, Kęstutis Herr, Ingrid Schemmer, Peter |
author_sort | Račkauskas, Rokas |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10603549 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-106035492023-10-28 [Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins Račkauskas, Rokas Zhou, Dachen Ūselis, Simonas Strupas, Kęstutis Herr, Ingrid Schemmer, Peter Oncol Rep Corrigendum D.A. Spandidos 2023-10-11 /pmc/articles/PMC10603549/ /pubmed/37830166 http://dx.doi.org/10.3892/or.2023.8646 Text en Copyright: © Račkauskas et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited. |
spellingShingle | Corrigendum Račkauskas, Rokas Zhou, Dachen Ūselis, Simonas Strupas, Kęstutis Herr, Ingrid Schemmer, Peter [Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins |
title | [Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins |
title_full | [Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins |
title_fullStr | [Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins |
title_full_unstemmed | [Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins |
title_short | [Corrigendum] Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins |
title_sort | [corrigendum] sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti‑apoptotic proteins |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603549/ https://www.ncbi.nlm.nih.gov/pubmed/37830166 http://dx.doi.org/10.3892/or.2023.8646 |
work_keys_str_mv | AT rackauskasrokas corrigendumsulforaphanesensitizeshumancholangiocarcinomatocisplatinviathedownregulationofantiapoptoticproteins AT zhoudachen corrigendumsulforaphanesensitizeshumancholangiocarcinomatocisplatinviathedownregulationofantiapoptoticproteins AT uselissimonas corrigendumsulforaphanesensitizeshumancholangiocarcinomatocisplatinviathedownregulationofantiapoptoticproteins AT strupaskestutis corrigendumsulforaphanesensitizeshumancholangiocarcinomatocisplatinviathedownregulationofantiapoptoticproteins AT herringrid corrigendumsulforaphanesensitizeshumancholangiocarcinomatocisplatinviathedownregulationofantiapoptoticproteins AT schemmerpeter corrigendumsulforaphanesensitizeshumancholangiocarcinomatocisplatinviathedownregulationofantiapoptoticproteins |